Breaking News: AstraZeneca admits its Covid-19 vaccine can cause rare side effects, including blood clots and low platelet levels. Find out more here!
AstraZeneca, the pharmaceutical giant behind the Covishield Covid-19 vaccine, has made a significant admission in court regarding the vaccine's rare side effects. The company acknowledged for the first time that Covishield can lead to Thrombosis Thrombocytopenia Syndrome (TTS), characterized by blood clots and low platelet counts. This revelation comes after a class action lawsuit raised concerns over the vaccine's safety and potential risks.
Developed in collaboration with the University of Oxford, AstraZeneca's Covid vaccine has faced scrutiny over its potential side effects. The company's admission sheds light on the rare but serious nature of TTS, which can manifest through symptoms like severe headaches and abdominal pain. Despite the widespread distribution of the vaccine under various brand names, including Covishield, these recent revelations highlight the importance of thorough monitoring and awareness of potential risks associated with vaccination.
In the midst of the global vaccination drive, AstraZeneca's acknowledgment serves as a reminder of the complexities and uncertainties surrounding vaccine development. While the benefits of vaccination in combating the Covid-19 pandemic are evident, the rare side effects underscore the need for continuous research and vigilance in evaluating vaccine safety. As the medical community continues to navigate the challenges of combating the virus, transparency and accountability remain paramount in ensuring public trust and confidence in vaccination programs.
In light of AstraZeneca's admission, individuals are advised to stay informed about the latest updates on vaccine safety and consult healthcare professionals for guidance. The evolving understanding of rare side effects like TTS underscores the dynamic nature of medical science and the ongoing efforts to enhance vaccine safety and efficacy. As the global community strives to overcome the pandemic, collaboration, transparency, and data-driven decision-making are essential in safeguarding public health and well-being.
TTS is characterized by blood clots (thrombosis) combined with low levels of platelets (thrombocytopenia), which are necessary for blood clotting. It often ...
The pharmaceutical company is being sued in a class action over claims that its vaccine against Covid-19, developed with the University of Oxford, ...
Pharmaceutical giant AstraZeneca has accepted for the first time that its Covid vaccine โcan, in very rare cases, cause TTSโ.
AstraZeneca admits Covishield's rare side effect TTS, causing blood clots with low platelets. TTS symptoms include severe headaches, abdominal pain. T.
In a legal battle, AstraZeneca admits its Covid-19 vaccine, sold under brand names like Covishield, may in very rare cases cause severe side effects ...
The vaccine, developed in collaboration with the University of Oxford, was distributed globally under various brand names, including Covishield and ...
AstraZeneca COVID Vaccine Side Effects: AstraZeneca has admitted for the first time in court documents that its Covid vaccine can cause rare side effects, ...
When the unexpected wave of the Covid-19 pandemic hit in 2020, medical science got busy finding a vaccine against the virus. Day in and day out, ...
British pharma giant AstraZeneca has admitted that its Covid vaccine can cause rare side effects, The Telegraph (UK) has reported.
However, research has since found that Covishield can cause some people to develop blood clots, which may prove fatal. A class action lawsuit filed in the UK ...
AstraZeneca admitted for the first time that its vaccine may cause a rare side effect called TTS · TTS is a condition characterised by blood clots and low blood ...
Jamie Scott alleges the pharmaceutical giant exaggerated the vaccine's effectiveness and downplayed its risks. AstraZeneca denies the claims made against ...
British pharmaceutical giant AstraZeneca has acknowledged that its Covid vaccine can lead to a rare blood clotting condition known as Thrombosis with ...
Pharmaceutical giant AstraZeneca in a damning revelation has admitted that its Covid-19 vaccine 'Covishield' can, in "very rare cases, cause TTS".
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the ...
AstraZeneca's COVID-19 vaccine may cause rare blood clotting syndrome, but doctors in India are well aware of the risk.
Pharmaceutical giant AstraZeneca admitted in court this week that its COVID-19 vaccine can cause a rare but deadly blood-clotting condition.
India Today spoke to doctors about AstraZeneca's admission and the rare side effect called TTS triggered by its Covid-19 vaccine.
This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare ...
The admission came a day after the pharma giant admitted in a UK court that its COVID-19 vaccine sold globally as Covishield and Vaxzevria may cause ...